Found 460 results in Expert Content

Summary: ​Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.

Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...

Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.

Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.

Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability.

Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery.

Summary: Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.

Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies.

Summary: This webinar provides an overview of co-amorphous research and its recent findings, particularly, the impact of low molecular weight excipient on developability, stability and solubility.

Summary: Learn about the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations.